设计,合成,生物活性和对接研究伊沙-化衍生物作为潜在的CDK-2抑制剂
Ye Tao1, Kaige Guo1, Xiaofen Liao2
1College of Jiyang, Zhejiang A&F University, Zhuji 311800, China.
Anti-cancer agents in medicinal chemistry
|January 26, 2026
概括
新型异酸衍生物通过抑制CDK2激酶,显示出强大的抗癌活性. 化合物2e,2f和2h对肺癌,宫癌和肝癌细胞系具有显著的选择性和有效性.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 化学生物学 化学生物学
背景情况:
- 伊萨衍生物是含有的异环,具有多种药理活动.
- 水子化合物在农药和药物化学中至关重要.
- 结合伊沙和酸骨架可能产生强烈的生物活性.
研究的目的:
- 合成新型的异酸-化衍生物.
- 评估它们作为循环素依赖性激酶2 (CDK2) 抑制剂的潜力.
- 通过分子对接和生物活性研究研究它们的抗癌特性.
主要方法:
- 使用NMR和HRMS合成和表征异酸衍生物.
- 通过MTT测定对A549,HepG2和HeLa癌细胞系进行体外细胞毒性评估.
- 分子对接以分析与CDK2活性位点的结合相互作用.
主要成果:
- 化合物2e和2f对A549 (IC50 = 5nM) 和HeLa (IC50 = 6nM) 细胞分别表现出强烈的活性.
- 化合物2h对A549 (IC50 = 8nM) 和HepG2 (IC50 = 13nM) 细胞表现出双重的疗效.
- 分子对接证实了活性衍生物与CDK2活性部位的强有力的结合亲缘关系.
结论:
- 新型异酸衍生物,特别是2e,2f和2h,显示出作为抗癌剂的巨大潜力.
- 这些化合物有效抑制CDK2激酶活性.
- 合成的衍生品需要进一步研究,作为癌症治疗的治疗候选物.
相关概念视频
Group Design
10.3K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.3K
Study Design in Statistics
10.0K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.0K
Study Designs in Epidemiology
938
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
938
Inhibition of Cdk Activity
5.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.8K
S-Cdk Initiates DNA Replication
5.5K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
5.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K


